Results 231 to 240 of about 462,118 (388)

Distribution of Angiotensin-Converting Enzyme and Angiotensin II-Receptor Binding Sites in the Rat Ovary1 [PDF]

, 1988
Robert C. Speth, Ahsan Husain
openalex   +1 more source

Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction

ESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi, Matteo Pagnesi, Rossana Corso, Antonio M. Sammartino, Daniela Tomasoni, Riccardo M. Inciardi, Carlo M. Lombardi, Marianna Adamo, Savina Nodari, Marco Metra   +9 more
wiley   +1 more source

Angiotensin-converting enzyme inhibitor-induced angioedema: Proposal for a diagnostic score. [PDF]

World Allergy Organ J
Bocquet A, Marmion N, Boccon-Gibod I, Bouillet L.   +3 more
europepmc   +1 more source

Partial Purification and Characterization of Angiotensin-Converting Enzyme in Mouse and Human Skin

, 1982
Akira Hara, Kimie Fukuyama, William L. Epstein   +2 more
openalex   +1 more source

Angiotensin-converting enzyme in cultured endothelial cells. Synthesis, degradation, and transfer to culture medium. [PDF]

, 1983
Shanfun Ching, Lyle W. Hayes, Linda L. Slakey   +2 more
openalex   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh, Katharina Koepsel, Julia W. Erath, Thomas Kuntz, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Christian Blockhaus, Dong‐In Shin, Fabienne Kreimer, Michael Gotzmann, Hendrik Lapp, Thomas Beiert, Assem Aweimer, Andreas Mügge, Christel Weiß, Ibrahim El‐Battrawy, Ibrahim Akin   +18 more
wiley   +1 more source

Impact of Angiotensin-Converting Enzyme Inhibitor on Coronary Artery Calcification Evaluated by Intravascular Ultrasound: A Retrospective Cohort Study. [PDF]

Health Sci Rep
Kanda D, Tokushige A, Ohmure K, Fukumoto D, Shimono H, Tabata H, Ito N, Kubozono T, Ohishi M.   +8 more
europepmc   +1 more source

Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril). [PDF]

, 1984
F. M. Fouad, Robert C. Tarazi, E L Bravo, Stephen C. Textor   +3 more
openalex   +1 more source

Connecting the dots: A narrative review of the relationship between heart failure and cognitive impairment

ESC Heart Failure, Volume 12, Issue 2, Page 1119-1131, April 2025.
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi, Maria Giulia Bellicini, Marianna Adamo, Andrea Pilotto, Marco Metra, Alessandro Padovani, Riccardo Proietti   +6 more
wiley   +1 more source

Increased or decreased thirst caused by inhibition of angiotensin‐converting enzyme in the rat.

, 1984
Mark D. Evered, Marilyn M. Robinson
openalex   +2 more sources